Delhi, 28th July 2022: Continuing its commitment to strengthening the delivery of global standards of clinical excellence, CK Birla Hospital® recently treated a 59-year-old male patient for severe swelling of the thyroid (goiter). The patient had been suffering from thyroid swelling for many years and over time the entire right neck was affected causing difficulty in neck movement. The patient had delayed surgery for many years because he feared the results and postoperative complications.
In thyroid surgeries in the best centers around the world, there is about a 25% risk of calcium dysregulation due to accidental removal or injury of the parathyroid glands (which control calcium levels in the human body and located very close to the thyroid gland) & 8% risk of injury to the vocal nerve, i.e. the recurrent laryngeal nerve also positioned just below the thyroid gland.
While examining the patient, Dr. Mandeep Singh Malhotra, Director of Surgical Oncology, CK Birla Hospital®, and his team recommended thyroidectomy treatment using NIFI and nerve monitoring. NIFI uses infrared technology to identify and preserve the parathyroid glands during thyroid surgery. The use of NIFI offers significant benefits to patients by reducing calcium disturbance post-thyroid surgery to
Commenting on the case, Dr. Mandeep Singh Malhotra, Director of Surgical Oncology, CK Birla Hospital® said, “This technology was previously available overseas, making it an expensive treatment option; but it is now available in Delhi, India at CK Birla Hospital®, making the treatment safer, accessible and affordable for Indian patients. A total of six thyroid surgeries have been performed using this advanced technology; three patients had thyroid cancer and three had large colloid goiters. The six patients had no calcium disturbance after surgery.
Near-infrared imaging is an effective technology for identifying the parathyroid gland during surgery. With its availability in India, better clinical outcomes can be offered to the patients. The adoption of this technology by CK Birla Hospital® is a step towards the Indian government‘s Make in India initiative.
Speaking on the occasion, Mr. Akshat Seth, Managing Director of CK Birla Healthcare, said, “We are committed to our goal of providing global standards of healthcare using advanced medical innovations and techniques for exceptional patient outcomes. The development of this medical technology in India is extremely helpful in saving lives. This case, like many others, is a testament to our legacy of delivering high quality health care services.
“Our center in Delhi, Punjabi Bagh, aims to advance the clinically trusted and patient-centered care that we stand for. The success of this case was an important milestone for us, reaffirming our state-of-the-art medical infrastructure and technology, clinical excellence and dedicated team of experts, said Mr. Vipul Jain, Chief Commercial Officer, CK Birla Hospital®.